Haematopoietic stem-cell transplantation in Crohn's disease

Affiliations

¹ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
² Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
³ Hospital Clinic de Barcelona, Gastroenterology Department, Barcelona, Spain.
⁴ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA. Electronic address: louis.cohen@mssm.edu.

Comment

Akshita Gupta et al. Lancet Gastroenterol Hepatol. 2024 Jun.

. 2024 Jun;9(6):499-500.

doi: 10.1016/S2468-1253(24)00055-4.

¹ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
² Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
³ Hospital Clinic de Barcelona, Gastroenterology Department, Barcelona, Spain.
⁴ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA. Electronic address: louis.cohen@mssm.edu.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Dickins B, Din S, Emsley R, Foulds GA, Gribben J, Hawkey C, Irving PM, Kazmi M, Lee E, Loban A, Lobo A, Mahida Y, Moran GW, Papaioannou D, Parkes M, Peniket A, Pockley AG, Satsangi J, Subramanian S, Travis S, Turton E, Uttenthal B, Rutella S, Snowden JA. Lindsay JO, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):333-345. doi: 10.1016/S2468-1253(23)00460-0. Epub 2024 Feb 7. Lancet Gastroenterol Hepatol. 2024. PMID: 38340759 Clinical Trial.